Daniël M Miedema

6PUBLICATIONS
10CO-AUTHORS
Cancer geneticsPredictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 21, 2022
Copy number heterogeneity identifies ER+ breast cancer patients that do not benefit from adjuvant endocrine therapy.

Tom van den Bosch, Oscar M Rueda, Carlos Caldas

|Apr 26, 2022
Copy-number intratumor heterogeneity as high-risk feature of stage II colon cancer<sup>†</sup>.

Tom van den Bosch, Daniël M Miedema, Louis Vermeulen

|Oct 07, 2021
Predicting survival of cancer patients by chromosomal copy number heterogeneity.

Tom Van Den Bosch, Erik van Dijk, Louis Vermeulen

|May 28, 2021
Chromosomal copy number heterogeneity predicts survival rates across cancers.

Erik van Dijk, Tom van den Bosch, Kristiaan J Lenos

|Aug 18, 2019
A marker-independent lineage-tracing system to quantify clonal dynamics and stem cell functionality in cancer tissue.

Kristiaan J Lenos, Sophie C Lodestijn, Scott K Lyons

Pageof 1